A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

Arthritis Rheum. 1989 Jul;32(7):817-25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Humans
  • Platelet-Derived Growth Factor / metabolism
  • Platelet-Derived Growth Factor / physiology
  • Scleroderma, Systemic / etiology*
  • Scleroderma, Systemic / metabolism
  • Scleroderma, Systemic / physiopathology
  • Transforming Growth Factors / physiology*
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Platelet-Derived Growth Factor
  • Tumor Necrosis Factor-alpha
  • Transforming Growth Factors